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A Meta-Analysis of the Effect of Exercise Training
on Left Ventricular Remodeling in Heart Failure Patients
The Benefit Depends on the Type of Training Performed
Mark J. Haykowsky, PHD,* Yuanyuan Liang, PHD,† David Pechter, BA,* Lee W. Jones, PHD,§
Finlay A. McAlister, MD, MSC, Alexander M. Clark, PHD‡
Edmonton, Alberta, Canada; and Durham, North Carolina
Objectives The aim of this study was to determine the effect of exercise training and type of exercise (aerobic vs. strength
vs. combined training) on left ventricular (LV) remodeling in heart failure (HF).
Background A number of randomized controlled trials have examined the effect of exercise training on LV remodeling in indi-
viduals with HF. However, the results of these trials have been inconclusive.
Methods The authors searched MEDLINE (1966 to 2006), Cochrane Central Register of Controlled Trials (issue #3, 2006),
CINAHL (1982 to 2006), EMBASE (1988 to 2006), PubMed (1966 to 2006), and reference lists of identified
studies for randomized controlled trials examining the effects of exercise training on ejection fraction (EF), end-
diastolic volume (EDV), and end-systolic volume (ESV) in clinically stable patients with HF. Primary study authors
were also contacted if appropriate. Studies were selected and data were extracted independently by 2 reviewers.
Weighted mean differences (WMD) were calculated using a random effects model.
Results Fourteen trials reported EF data (n  812 patients). Seven trials reported both EDV and ESV data (n  569).
Aerobic training significantly improved EF (9 trials, 538 patients, WMD  2.59%; 95% confidence interval [CI]
1.44% to 3.74%), EDV (371 patients; WMD  11.49 ml; 95% CI 19.95 to 3.02 ml) and ESV (371 patients;
WMD  12.87 ml; 95% CI 17.80 to 7.93 ml). Combined aerobic and strength training was not associated
with significant improvements in EF, EDV, or ESV.
Conclusions Aerobic training reverses LV remodeling in clinically stable individuals with HF. This benefit was not confirmed
with combined aerobic and strength training. (J Am Coll Cardiol 2007;49:2329–36) © 2007 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.02.055d
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teart failure (HF) is an increasingly common syndrome
ssociated with poor prognosis and high health care costs
1). A cardinal feature of HF is the progressive chamber
ilation and deterioration in pump function resulting from
ncreased hemodynamic load and neurohormonal stress.
his process, termed left ventricular (LV) remodeling
2), is associated with increased morbidity and mortality;
herefore, interventions that halt or reverse ventricular
emodeling should improve these clinical outcomes. In-
rom the *Faculty of Rehabilitation Medicine, †Alberta Research Centre for Child
ealth Evidence, and ‡Faculty of Nursing, University of Alberta, Edmonton,
lberta, Canada; §Department of Surgery, Duke University Medical Center,
urham, North Carolina; and the Division of General Internal Medicine, University
f Alberta Hospital, Edmonton, Alberta, Canada. Dr. Haykowsky holds a Canadian
nstitutes of Health Research (CIHR) New Investigator award. Drs. Clark and
cAlister hold salary awards from the Alberta Heritage Foundation for Medical
esearch. Dr. McAlister also holds a CIHR New Investigator Award and the Merck
rosst/Aventis Chair in Patient Health Management at the University of Alberta.s
Manuscript received December 14, 2006; revised manuscript received Feburary 16,
007, accepted February 20, 2007.eed, the favorable benefits associated with pharmaco-
ogic, electrophysiologic, or device therapies are due, in
art, to these therapies’ ability to slow or reverse LV
emodeling (3–8).
See page 2337
As part of the cadre of interventions to manage HF
ffectively, exercise training is now recommended by a
umber of international scientific organizations for patients
ith mild to moderate HF symptoms (9,10). This recogni-
ion stems from studies reporting that exercise training can
mprove peak oxygen consumption (VO2peak) (9–11), mus-
le strength and mass (11), New York Heart Association
unctional class (12), and quality of life (9,13) in HF
atients. Although exercise training can restore the abnor-
al autonomic, neurohormonal, and hemodynamic func-
ion associated with the HF syndrome (12,14–16), and, in
ome studies (17), has been shown to reverse LV remodel-
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Exercise Training and Ventricular Remodeling June 19, 2007:2329–36ing in clinically stable HF pa-
tients, several other investigators
(18,19) reported no benefits
with exercise training on LV
end-diastolic volume (EDV),
end-systolic volume (ESV), or
ejection fraction (EF). Thus, un-
certainty remains regarding the
effects of exercise training on LV
remodeling in patients with HF.
In an attempt to resolve this
issue, we performed a meta-
analysis to examine the effects of
exercise training on these out-
comes and determine whether
the type of exercise training in-
fluenced these effects.
ethods
ata sources. The authors searched MEDLINE (1966 to
006); Cochrane Central Register of Controlled Trials
issue #3, 2006), CINAHL (1982 to 2006), EMBASE
1988 to 2006), PubMed (1966 to 2006) using the following
ESH terms and text words: heart failure, exercise, exercise
herapy, exercise test, therapeutic exercise, cardiac rehabilitation,
nd kinesiotherapy. We also hand-searched reference lists of
ll identified studies, previous systematic reviews (20), and
he Cochrane Collaboration’s review of exercise rehabilita-
ion for HF. We excluded non-English articles.
tudy selection. Two investigators (M.J.H. and A.M.C.)
ndependently reviewed the titles and abstracts of all cita-
ions to identify studies reporting the effect of exercise
raining on EF and/or LV volumes in patients with HF.
oth investigators obtained the full text of potentially
elevant articles and independently reviewed them using
restandardized data abstraction forms and eligibility crite-
ia defined a priori. We excluded studies that were not
andomized or were crossover trials, did not have a usual
are control group, had an intervention group that also
eceived a pharmacologic intervention, or had HF patients
ho were not clinically stable for at least 1 month before the
xercise intervention.
ata extraction and quality assessment. The 2 investiga-
ors extracted all outcome data independently. When nec-
ssary, original investigators were contacted to clarify data.
uthors for 2 studies provided further data. Quality was
ssessed using the previously validated Jadad scale (21) (a
-point scale based on adequacy of reporting for random-
zation, double-blinding, and disclosure of withdrawals and
ropouts) and adequacy of allocation concealment.
ata synthesis and analysis. Data were analyzed using the
hange from baseline data for both exercise and control
roups. Results were combined as weighted mean differ-
nces (WMD) with 95% confidence intervals (CI) using a
andom effects model. Heterogeneity was quantified using
Abbreviations
and Acronyms
CI  confidence interval
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
HF  heart failure
LV  left ventricle/
ventricular
SMD  standardized mean
difference
VO2peak  peak oxygen
consumption
WMD  weighted mean
differencehe I2 statistic. As we anticipated heterogeneity on the basis 2f type of exercise, we planned to explore differences in
ffects for different types of exercise training (aerobic train-
ng, strength training, or combined aerobic and strength
raining). Sensitivity analyses were performed to examine
he robustness of the effect by using standardized mean
ifference (SMD) for LV volume data. In addition, we
onducted sensitivity analyses to determine whether blind-
ng of the person assessing EF, EDV, and ESV to group
llocation influenced the magnitude of any observed effects.
ublication bias was tested visually using the funnel plot
22) and quantitatively using the Begg adjusted-rank corre-
ation test (23) and Egger regression asymmetry test (24).
esults
tudy selection and evaluation. We identified 1,647 cita-
ions from electronic databases. After initial screening, 19
ull manuscripts were reviewed, but 5 of these manuscripts
ere excluded because they did not report EF (n  2), did
ot include a control group (n  2), or were an additional
ublication from an already included trial (n  1) (Fig. 1).
tudies included in the systematic review. Fourteen
nique randomized trials were identified (Table 1).
12,13,17–19,25–33). The trials included clinically stable
atients with HF symptoms and impaired LV systolic
unction (weighted mean EF  23%), who were relatively
oung (mean age 57  5 years) and predominantly men
89%). Most trials incorporated aerobic training at an
ntensity between 60% and 80% of baseline VO2peak for 20 to
0 min per exercise session (12,13,17,19,26–28,31,33)
Table 1). Four trials examined the effects of combined
erobic and strength training (18,29,30,32), and one trial
xamined strength training alone (25). The length of the
raining program varied between 2 and 12 months.
No trial was double-blind (which is not surprising given
he type of intervention), and very few trials described
andomization procedures. Only 4 trials (12,17,18,25)
tated that the persons assessing EF, EDV, and ESV were
linded to group allocation (i.e., blinded ascertainment of
utcomes). Therefore, trials scored relatively poorly on the
adad scale: 7 received a score of 1 of 5, 5 studies received a
core of 2 of 5, and 2 studies scored 3 of 5.
uantitative data synthesis. EXERCISE TRAINING AND LV
JECTION FRACTION. Although exercise training was asso-
iated with a significant improvement in EF when data
rom all trials were pooled (14 trials; 812 patients; WMD
.83%; 95% CI 0.45% to 3.21%), this analysis demonstrated
ubstantial heterogeneity (I2 49.2%). However, the results
rom the trials of aerobic training demonstrated relatively
onsistent benefits in EF (9 trials, 538 patients, WMD 
.59%; 95% CI 1.44% to 3.74%, I2  17.2%) (Fig. 2). The
trial testing strength training alone was inconclusive
WMD in EF  4.5%, 95% CI 13.14% to 4.14%).
rials testing combined training (aerobic plus strength
xercise) were also inconclusive (4 trials, 249 patients,
MD for EF  0.37%; 95% CI 2.23% to 2.97%, I2 5.7%).
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June 19, 2007:2329–36 Exercise Training and Ventricular RemodelingXERCISE TRAINING AND LEFT VENTRICULAR VOL-
MES. Seven of 14 trials examined the effect of exercise
raining on LV volumes (12,13,17–19,32,33). Aerobic
raining was performed in 5 of these trials (12,13,17,19,33);
ombined aerobic and strength training was performed in
he remaining trials (18,32). Overall, exercise training was
ssociated with a significant decline in EDV (569 patients;
MD  9.75 ml; 95% CI 16.64 to 2.86 ml) and
SV (569 patients; WMD  12.31 ml; 95% CI 17.12
o 7.49 ml). Although aerobic training led to significant
mprovements in EDV (371 patients; WMD11.49 ml;
5% CI 19.95 to 3.02 ml) and ESV (371 patients;
MD  12.87 ml; 95% CI 17.80 to 7.93 ml) (Figs.
and 4), the effects of combined aerobic and strength
raining were inconclusive for both EDV (198 patients;
MD  0.39 ml; 95% CI 25.84 to 26.62 ml, I2 
%) (Fig. 3) and ESV (WMD  0.73 ml; 95% CI
23.19 to 21.72 ml; I2  0%) (Fig. 4).
Given that the investigators of 2 aerobic intervention
rials (17,33) referenced their volume data to body surface
rea, and the remaining aerobic trials reported absolute
olumes, we performed sensitivity analysis using the SMD.
hese results further confirmed that aerobic training was
ssociated with a significant and favorable decline in EDV
SMD  0.36; 95% CI 0.56 to 0.15; I2  0%) and
SV (SMD0.50; 95% CI0.72 to0.28; I2 8.6%).
Our analysis of the impact that blinding of the person
ssessing EF, EDV, and ESV had on the observed results
Figure 1 Flow of Trials Through the Selection Processevealed an inconsistent effect. For EF, the 4 trials that veported blinded ascertainment of outcomes reported a
maller and less consistent effect with exercise training
blinded trials: WMD  0.80%, 95% CI 2.86% to 4.46%
ut with 83% heterogeneity; nonblinded trials: WMD 
.17%, 95% CI 1.00% to 3.34% with 0% heterogeneity).
owever, the blinded outcome ascertainment trials reported
onsignificantly greater benefits than the nonblinded out-
ome trials on EDV (blinded trials: WMD  15.5 ml,
5% CI 35.81 to 4.80 ml; nonblinded trials: WMD 
7.14 ml, 95% CI 13.80 to 0.48 ml) and ESV (blinded
rials: WMD  16.91 ml, 95% CI 30.78 to 3.04 ml;
onblinded trials: WMD 11.08 ml, 95% CI 16.44 to
5.71 ml).
DDITIONAL END POINTS. Aerobic exercise training was
ssociated with a statistically significant increase in VO2peak
9 trials; 538 patients; WMD 2.98 ml·kg·min1; 95% CI
.47 to 3.49 ml·kg·min; I216.3%), whereas the effect of
ombined aerobic and strength training on this end point
emains uncertain (88 patients; WMD  1.83 ml·kg·min;
5% CI 1.87 to 5.53 ml·kg·min; p value for heteroge-
eity  0.002; I2  83.7%).
ublication bias. There was no evidence of publication
ias (Begg adjusted-rank correlation test, p  0.66; Egger
egression asymmetry test, p  0.92).
iscussion
his review indicates that aerobic exercise training reverses
entricular remodeling in clinically stable individuals with
Description of Included Studies
Table 1 Description of Included Studies
Study, Year (Ref.) Study Sample Sample Size, n Men, %
Mean Age,
yrs
Key Components of Exercise
Intervention
Duration of
Intervention, months
Method Used to
Measure EF
Drug
Therapy (%)
Koch et al., 1992 (25) NYHA functional class II–III HF
(etiology: IC or IDC), LVEF40%
EXT, 12 67 56 ST (KOCH bench) 90 min per session
 40 sessions over 90 days using
small number of muscle groups
3 Echo ACE: 92
BB: NR
DIU: 50
CNT, 13 85 54 — 3 ACE: 100
BB: NR
DIU: 85
Belardinelli et al., 1995 (26) NYHA functional class II–III HF
(etiology: IC and IDC)
EXT, 36 86 55 AT (CE), 3 days/week at 60% VO2peak
 40 min
2 Echo ACE: 92
BB: NR
DIU: 83
CNT, 19 84 54 — 2 ACE: 100
BB: NR
DIU: 84
Belardinelli et al., 1996 (27) Clinically stable HF (etiology: IC) EXT, 29 93 55 AT (CE), 3 days/week at 60% VO2peak
 40 min
2 RV ACE: 83
BB: NR
DIU: 100
CNT, 14 79 54 — 2 ACE: 79
BB: NR
DIU: 100
Kiilavuori et al., 1996 (28) NYHA functional class II–III HF
(etiology: IC or IDC), LVEF40%
EXT, 12 100 52 AT (CE, ROW, SW, WLK) 3 days/week at
50–60% VO2peak  30 min
6 Echo ACE: 92
BB: 33
DIU: 92
CNT, 15 93 52 — 6 ACE: 93
BB: 13
DIU: 73
Belardinelli et al., 1999 (13) NYHA functional class II–IV HF
(etiology: IC or IDC), LVEF 40%
EXT, 50 90 56 AT (CE), 2–3 days/week at 60% VO2peak
 40 min
14 Echo ACE: 90
BB: NR
DIU: 92
CNT, 49 88 53 — 14 ACE: 88
BB: NR
DIU: 90
Hambrecht et al., 2000 (12) NYHA functional class I–III HF
(etiology: IC or IDC),
LVEF40%, peak power
output25 W
EXT, 36 100 54 AT (CE), 7 days/week at 70% VO2peak
 20–60 min
6 Echo ACE: 94
BB: 8
DIU: 78
CNT, 37 100 55 — 6 ACE: 95
BB: 16
DIU: 78
McKelvie et al., 2002 (18) NYHA functional class I–III HF
(etiology: IC, IDC, HYP, VALV),
LVEF 40%, 6MWD500 m
EXT, 90 82 65 AT (AE, CE, TM, WLK), 2–3 days/ week at
60%–70% HRmax  30 min plus ST (AC,
KE, LP) 2–3 days/week, 1–3 sets
10–15 repetitions at 40%–60% 1RM
12 RV ACE: 91
BB: 20
DIU: 81
CNT, 91 80 66 — 12 ACE: 92
BB: 23
DIU: 86
Myers et al., 2002 (19) NYHA functional class II–III HF
(etiology: IDC)
EXT, 12 83 53 AT (CE), 5 days/week at 60%–80%
VO2max and BORG RPE 13–15 
45 min
2 CM ACE: 100
BB: 75
DIU: 83
Continued on next page
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Continued
Table 1 Continued
Study, Year (Ref.) Study Sample Sample Size, n Men, %
Mean Age,
yrs
Key Components of Exercise
Intervention
Duration of
Intervention, months
Method Used to
Measure EF
Drug
Therapy (%)
CNT, 12 83 58 — 2 ACE: 92
BB: 75
DIU: 83
Giannuzzi et al., 2003 (17) NYHA functional class II–III HF
(etiology: IC, IDC, VALV), LVEF
35%, VO2peak 20 ml·kg·min
1
EXT, 45 100 60 AT (CE, WLK), 3 to 5 days/week at 60%
VO2peak  30–60 min
6 Echo ACE: 91
BB: 22
DIU: 91
CNT, 45 100 61 — 6 ACE: 93
BB: 20
DIU: 91
Roveda et al., 2003 (29) NYHA functional class II–III HF (IC,
IDC, Chagas), LVEF 40%
EXT, 7 71 53 AT (CE), 3 days/week at HR at AnT  25
to 40 min plus ST (sit-ups, push-ups,
pull-ups)  10 min
4 NR ACE: 100
BB: 0
DIU: 100
CNT, 9 67 53 — 4 ACE: 100
BB: 0
DIU: 78
Sabelis et al., 2004 (30) NYHA functional class II–III HF
(etiology: IC or IDC)
EXT, 16 100 60 AT (CE-INT training) 4 days/week at 50%
VO2peak and 70% HRpeak for 11–50
min plus ST (5BX program
strengthening the abdominal, gluteal,
posterior leg and arm muscles)
4 days/week
6.5 Echo Data reported for
all subjects
ACE: 79
BB: 45
DIU: 45
CNT, 13 100 60 — 6.5
Klocek et al., 2005 (31) NYHA functional class II–III HF
(etiology: IC), LVEF40%
EXT, 28 100 56 AT (n  14, CE), 3 days/week at 60%
HRmax  25 min (INT). AT (n  14,
CE), 3 days/week at 75% HRmax 
25 min (CONT)
6 Echo ACE: 100
BB: 54
DIU: 100
CNT, 14 100 55 — 6 ACE: 100
BB: 57
DIU: 100
Jonsdoittir et al., 2006 (32) NYHA functional class II–III HF
(etiology: IC, AF, VALV, HYP)
EXT, 21 76 68 AT (CE), 2 days/week at 50% PPO  15
min plus ST (CWT) of arms and legs at
20%–40% 1RM  20 min
5 Echo ACE: 38
BB: 52
DIU: 81
CNT, 22 82 69 — 5 ACE: 23
BB: 64
DIU: 86
Passino, et al., 2006 (33) NYHA functional class I–III HF
(etiology: IC, IDC), LVEF45%,
VO2peak25 ml·kg·min
1
EXT, 44 89 60 AT (CE, 3 days/week at 65% VO2peak
 30 min)
9 NR ACE: 78
BB: 72
DIU: 100
CNT, 41 85 61 — 9 ACE: 79
BB: 73
DIU: 100
AC  arm curl; ACE  angiotensin converting enzyme inhibitor; AE  arm ergometer; AF  atrial fibrillation; AnT  anaerobic threshold; AT  aerobic training; BB  beta-blocker; BORG RPE  Borg rate of perceived exertion; CE  cycle ergometer; CM  cardiac magnetic
resonance imaging; CNT  control group; CONT  continuous aerobic training; CWT  circuit weight training; DIU  diuretic; ECHO  echocardiography; EXT  exercise training group; HF  heart failure; HR  heart rate; HRmax  maximal heart rate; HYP  hypertensive;
IC  ischemic cardiomyopathy; IDC  idiopathic dilated cardiomyopathy; INT  interval training; KE  knee extension; LP  leg-press; LVEF  left ventricular ejection fraction; NR  not reported; NYHA  New York Heart Association; PPO  peak power output; RM 
one-repetition maximum; ROW rowing; RV radionuclide ventriculography; ST strength training; SW swimming; TM treadmill; VALV valvular; VO2peak peak aerobic power; VO2maxmaximal aerobic power; WLK walking; 6MWD distance walked in 6 min.
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Exercise Training and Ventricular Remodeling June 19, 2007:2329–36F. The favorable changes in LV volumes and EF associ-
ted with aerobic training were supplementary to pharma-
ologic benefits; that is, they occurred despite the patients
eing prescribed medications with a proven antiremodeling
ffect (Table 1). Overall, the magnitude of the improvement
n EF is consistent with the magnitude of benefits seen with
ngiotensin-converting enzyme inhibitors or cardiac resyn-
hronization therapy (3,34).
The mechanism whereby aerobic training attenuates LV
emodeling is not known; however, it may be due to the
eduction in vasoconstrictive neurohormones or a decline in
Figure 2 Exercise Training and Ejection Fraction
AT  aerobic training; CI  confidence interval; ST  strength training; WMD  w
Figure 3 Exercise Training and End-Diastolic Volume
Abbreviations as in Figure 2.emodynamic loading. Braith et al. (14) and others
12,15,33) have reported that aerobic training reduces rest-
ng plasma angiotensin II, aldosterone, vasopressin, atrial
atriuretic peptide, brain natriuretic peptide, epinephrine,
nd norepinephrine levels. Coats et al. (16) also reported
hat short-term aerobic training is associated with a decrease
n sympathetic tone and a concomitant increase in vagal
ctivity in stable HF patients. The improved sympathovagal
alance, coupled with the decline in vasoconstrictive neu-
ohormones, is associated with a reduction in vascular load
hat may attenuate LV remodeling. Indeed, Hambrecht
mean differences.eighted
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June 19, 2007:2329–36 Exercise Training and Ventricular Remodelingt al. (12,15) have shown that the reduction in resting LV
nd-diastolic volume and increase in peak exercise stroke
olume that occurred with aerobic training were related to
he decline in resting and peak exercise systemic vascular
esistance, respectively (12). Belardinelli et al. (27,35) ex-
ended these findings by demonstrating that aerobic training
lso improves myocardial contractility and diastolic filling in
ndividuals with ischemic cardiomyopathy and impaired LV
ystolic function. Our finding of increased EF after aerobic
raining is likely attributable to enhanced preload, myocar-
ial contractility, and vascular reserve.
An unexpected finding was that strength training was not
ssociated with demonstrable benefit in LV remodeling;
ndeed, the favorable antiremodeling role of aerobic exercise
as not confirmed when this mode of exercise was com-
ined with strength training. This may be because of the
eightened systolic and diastolic pressure loading that oc-
urs with strength training (36–38). Moreover, the
trength-training-mediated increase in LV wall stress, cou-
led with the impaired contractile and preload reserve, could
xplain why LV stroke volume and EF do not increase when
F patients perform this type of exercise (36,37).
Our finding that aerobic training is associated with a
ignificant increase in VO2peak is similar to previous systematic
eviews that examined the effect of exercise rehabilitation on
linical outcomes in HF (39,40). Indeed, a recent meta-
nalysis by Piepoli et al. (41) found that exercise training was
ssociated with a reduction in overall mortality in individuals
ith HF. Importantly, 8 of the 9 trials included in their
nalysis incorporated aerobic exercise training. A limitation of
revious meta-analyses (39,40) is that they did not examine the
ffect of exercise or mode of exercise training on LV remod-
ling. Also, in contrast to previous reviews (20,39), we excluded
tudies that were not strictly randomized.
tudy limitations. As with most meta-analyses, our con-
Figure 4 Exercise Training and End-Systolic Volume
Abbreviations as in Figure 2.lusions are constrained by the restricted nature of trial narticipants: the vast majority of HF patients in these trials
ere clinically stable younger men with systolic dysfunction,
hich is not typical of the demographic profile in
opulation-based studies of HF patients (42). A more
epresentative population is currently being recruited to the
F-ACTION trial, the largest randomized controlled trial
o date examining the effect of exercise training on clinical
utcomes in HF (9). Another limitation of our analysis is
ow use of beta-blockers in the studies included. Indeed,
eta-blockers have been shown to have a greater effect on
V size and ejection fraction compared to that found with
xercise training in this meta-analysis (8). An additional
imitation is the lack of trials examining the effect of
trength training alone on LV remodeling. Finally, our
onclusions were constrained by the quality of the trials
eviewed, the majority of which did not incorporate blind-
ng at any stage. In particular, only 4 of these trials included
linded outcomes ascertainment (i.e., the persons assessing
F, EDV, and ESV were not blinded to treatment group
llocation in most of these trials). Although we did not find
consistent difference in the effects demonstrated in blinded
nd nonblinded trials, future trials of the impact of exercise
raining on LV remodeling should incorporate blinded
utcomes ascertainment, given the known interobserver
ariability in assessments of EF, EDV, and ESV with
urrent techniques.
onclusions
erobic training is an inexpensive and effective nondrug,
ondevice, nonsurgical intervention that reverses ventricular
emodeling and improves VO2peak in clinically stable individu-
ls with HF and LV systolic dysfunction. These benefits were
ot confirmed with combined aerobic and strength training.
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